Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): A randomized, noninferiority phase II trialwith a pharmacogenetic analysis

Constenla Figueiras, Manuel

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/1029

PMID: 25601966

DOI: 10.1634/theoncologist.2014-0379

ISSN: 1083-7159

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2015

Journal title

ONCOLOGIST

Type of content

Artigo